Biogen could look to buy Vertex; Takeda cozies up to Boston biotechs;

@FierceBiotech: ICYMI yesterday: Failed Alzheimer's drug wins $117M in vTv's IPO. Article | Follow @FierceBiotech

@JohnCFierce: 125 ex-$GSK R&D staffers in RTP face the ax--again (Great industry. Where else can you get fired twice in 8 months?) News | Follow @JohnCFierce

> Biogen ($BIIB), reeling after some commercial and clinical disappointments, may need to make a big acquisition to stay afloat, analysts say, and Vertex Pharmaceuticals ($VRTX) could be the ideal candidate. News

> Eisai has signed a deal with Halozyme ($HALO) to test whether the Japanese drugmaker's eribulin can treat advance breast cancer in combination with the latter company's PEGPH20. More

> Takeda, a Japanese company that recently appointed its first foreign CEO, is working to raise its profile in the Boston biotech scene. Story

Medical Device News

@FierceMedDev: FierceDiagnostics story: Foundation Medicine trips in Q2 with sluggish test reimbursement. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: NeuWave Medical gets FDA clearance for software upgrade to its ablation system. Report | Follow @VarunSaxena2

@EmilyWFierce: It's not a good week to be a drugmaker in Romania. More from FiercePharma | Follow @EmilyWFierce

> Upstart gets $6M to back the first FDA-cleared, OTC conception assistance device. Story

> Lombard Medical gains a second stent graft for aneurysm repair via $50M acquisition. Article

> CMS expands Medicare coverage of speech-generating devices. Report

Pharma News

@FiercePharma: IDEXX shares climb on record diagnostics placements and Q2 earnings gain. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: As Hospira expands recall of ketorolac to 37M vials you've got to wonder what Pfizer thinks. Story | Follow @EricPFierce

@CarlyHFierce: Celgene fights for sanction on patent challenger Bass. More | Follow @CarlyHFierce

> GSK hiring 130 at inhaler facility, even as CRO axes up to 200 GSK alum. Report

> Romania launches bribery probe into 11 drugmakers. Article

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.